Jan Starý

18PUBLICATIONS
195CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 24, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.

|Jan 20, 2026
Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Felicia Andresen, Ayami Yoshimi, Peter Bader

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Oct 17, 2024
Auer rod-positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature.

Ondrej Hrusak, Jitka Stancikova, Elena Vodickova

|Jun 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies.

Sarah Elitzur, Ruth Shiloh, Jan L C Loeffen

Pageof 3

Frequent Collaborators

9 joint publications

Andishe Attarbaschi

8 joint publications

Sarah Elitzur

8 joint publications

Martin Schrappe

7 joint publications

Franco Locatelli